RecruitingNCT07316556

Post-Marketing Surveillance of Vliwazell® Prowound Dressing

Prospective Systematic Data Collection for Post-Marketing Surveillance of Vliwazell® Pro Wound Dressing


Sponsor

Lohmann & Rauscher

Enrollment

208 participants

Start Date

Mar 11, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell® Pro. The aim of the study is to validate the performance of Vliwazell® Pro within its intended purpose and certified indications during routine use, and to gather additional safety data. The study will examine how the use of the dressing affects the condition of the skin surrounding the wound, the wound status in terms of exudate, wound odor, and other parameters. Furthermore, the satisfaction of healthcare providers and patients with the application of the dressing will be assessed.


Eligibility

Min Age: 18 Years

Inclusion Criteria17

  • Wound according to indication mentioned in the instructions for use:
  • Superficial acute and chronic wounds with moderate to very high amounts of exudate and that are superficial, in:
  • arterial and venous ulcers
  • diabetic ulcers
  • pressure ulcers
  • post-traumatic wounds
  • post-operative wounds healing by secondary intention
  • skin graft donor sites
  • oncological wounds
  • ulcerating tumors
  • wounds at risk of infection
  • superficial 2nd degree burns
  • lymphatic wounds
  • As secondary dressing on laparotomy wounds and fistulas or for deep wounds when used with appropriate wound filler
  • Patient has full legal capacity
  • Patient is able to understand and provide information
  • Patient has signed the written Informed Consent Form

Exclusion Criteria8

  • Age \< 18 years
  • Patient with contraindication:
  • Known allergy and/or hypersensitivity to any of the product components.
  • Not for use in tunnel-forming wound pockets, as the product may expand considerably with the absorption of wound exudate.
  • Not for use on dry wounds.
  • Pregnant or lactating women
  • Patients participating in another clinical trial at the time of inclusion
  • Patient not covered by health insurance/social security

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

Wundmanagement

Aachen, Germany

MVZ Hausärzte

Brüggen, Germany

ORGAMed

Dortmund, Germany

Hautklinik

Erlangen, Germany

Krankenhaus Tabea

Hamburg, Germany

WKM Rösner Mönchengladbach

Mönchengladbach, Germany

Gesundheitsmanager, Inh. Christine Bertram

Waidhaus, Germany

WKM Rösner Willich

Willich, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07316556